- Replication stress refers to any condition that slows, stalls or destabilises DNA replication forks, threatening the accurate duplication of the genome. Because DNA replication must proceed with extraordinary precision, even minor disturbances can generate single‑strand gaps, fork collapse and DNA double‑strand breaks (DSBs). Persistent replication stress is one of the most potent sources of genomic instability and a defining feature of cancer cells, which often replicate under conditions of chronic DNA damage, oncogene activation and metabolic imbalance.
- Replication stress arises from diverse sources. Endogenous triggers include tightly packed chromatin, repetitive DNA sequences, transcription–replication conflicts and shortages of nucleotides. Exogenous triggers include ultraviolet radiation, chemotherapeutic agents, oxidative stress and environmental toxins. Oncogene activation—such as MYC, RAS or Cyclin E—drives excessive replication origin firing, overwhelming the replication machinery and generating widespread fork stalling. In all cases, the fundamental problem is the same: the replication fork encounters obstacles it cannot easily bypass, leading to instability and potential collapse.
- Cells respond to replication stress through a highly coordinated signalling network centred on ATR kinase. ATR is activated when replication protein A (RPA) coats stretches of single‑stranded DNA generated at stalled forks. Once activated, ATR phosphorylates numerous substrates, including CHK1, to slow cell‑cycle progression, stabilise replication forks and prevent premature mitotic entry. This checkpoint response buys time for repair and ensures that damaged DNA is not passed to daughter cells. ATR signalling also interfaces with ATM, the kinase activated by DSBs, linking replication stress to the broader DNA‑damage response and the MRN complex.
- Stalled replication forks must be stabilised to prevent collapse. Proteins such as BRCA1, BRCA2, RAD51, FANCD2 and the BLM helicase protect stalled forks from nucleolytic degradation. BRCA1 and BRCA2 are particularly important: they promote RAD51 filament formation on stalled forks, shielding them from MRE11‑mediated degradation. When these protective mechanisms fail, forks collapse into DSBs, which require repair through homologous recombination. This makes replication stress intimately connected to the pathways controlled by MRE11, RAD50 and NBS1.
- Replication stress also generates complex DNA structures such as reversed forks, R‑loops and under‑replicated regions that persist into mitosis. Under‑replicated DNA can lead to chromosome bridges, micronuclei and chromosomal breakage during cell division. These aberrations contribute to chromosomal instability, a hallmark of cancer. In tumour cells, replication stress is both a vulnerability and a driving force: oncogene‑driven proliferation increases stress, while defects in repair pathways amplify genomic instability and accelerate tumour evolution.
- The consequences of replication stress extend beyond DNA damage. Stalled forks activate inflammatory signalling through cytosolic DNA fragments, which can engage cGAS–STING pathways and promote chronic inflammation. Replication stress also interacts with the proteostasis network and the oxidative stress response, as misfolded proteins and reactive oxygen species exacerbate replication challenges. These interconnected stress pathways shape cellular fate decisions, including senescence, apoptosis and necroptosis.
- Clinically, replication stress is a major therapeutic target. Cancer cells, which operate under chronic replication pressure, are hypersensitive to agents that further destabilise replication forks. ATR inhibitors, CHK1 inhibitors, WEE1 inhibitors and PARP inhibitors exploit this vulnerability by pushing stressed tumour cells beyond their repair capacity. Tumours with BRCA1 or BRCA2 mutations, defective homologous recombination or impaired fork protection are particularly sensitive to these therapies. Conversely, excessive replication stress contributes to resistance mechanisms, tumour heterogeneity and aggressive disease progression.
- In summary, replication stress is a central driver of genome instability and a defining feature of cancer biology. Through its effects on replication fork dynamics, checkpoint signalling, DNA repair and chromosomal integrity, replication stress shapes cellular survival, tumour evolution and therapeutic response. Understanding how cells detect, stabilise and repair stalled forks provides crucial insight into genome maintenance and offers powerful opportunities for targeted cancer therapy.
